Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine Model
Ju Hwan Jeong(Chungbuk National University), Min‐Suk Song(Chungbuk National University), Woong Hee Lee(Chungnam National University), Santosh Chokkakula(Chungbuk National University), Beom Kyu Kim(Chungbuk National University), Sol Oh(Chungbuk National University), On Bi Park(Cheongju University), Jihyun Park(Chungbuk National University), Ji Won Jung(Daegu Catholic University), Seong Ju Ahn(Cheongju University), Eung‐Gook Kim(Chungbuk National University), Ji Min Jung(Daegu Catholic University), Seong Cheol Min(Chungbuk National University)
Cited by 2
Related Papers
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
|Antiviral Research|2022|82
Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy
|Microorganisms|2023|77
SARS-CoV-2 drug resistance and therapeutic approaches
|Heliyon|2025|44
Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain
|Experimental & Molecular Medicine|2016|28
Molecular surveillance of antimicrobial resistance and transmission pattern of <i>Mycobacterium leprae</i> in Chinese leprosy patients
|Emerging Microbes & Infections|2019|22